← Eichor
Study identifier: NCT01258231 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Identification of Genomic Predictors of Adverse Events After Cardiac Surgery

Condition: Heart; Dysfunction Postoperative, Cardiac Surgery · Genetic Predisposition to Disease · Atrial Fibrillation  ·  Sponsor: Brigham and Women's Hospital

PhaseN/A
Planned participants4000
Who can joinAll sexes, 20 Years to 90 Years
Healthy volunteersNo

About this study

This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure. Patients undergoing heart surgery at Brigham and Women's Hospital and Texas Heart Institute are eligible to participate.

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (3)

Brigham and Women's HospitalBoston, Massachusetts, United StatesCompleted
UT Southwestern Medical CenterDallas, Texas, United StatesRecruiting
Department Texas Heart Institute at St. Luke's Episcopal HospitalHouston, Texas, United StatesCompleted

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT01258231